Home > Financial Ratios > ANTHEM BIOSCIENCES

ANTHEM BIOSCIENCES
Core EBITDA Margin

    Back to All Ratios
ANTHEM BIOSCIENCES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ANTHEM BIOSCIENCES
Please provide your vote to see the results

ANTHEM BIOSCIENCES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 38.2036.2635.5940.0146.06

What is the latest Core EBITDA Margin ratio of ANTHEM BIOSCIENCES ?

The latest Core EBITDA Margin ratio of ANTHEM BIOSCIENCES is 38.20 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar202638.20
Mar202536.26
Mar202435.59
Mar202340.01
Mar202246.06

How is Core EBITDA Margin of ANTHEM BIOSCIENCES Trending?

Years Core EBITDA Margin % Change
Mar2026 38.2
5.35
Mar2025 36.26
1.88
Mar2024 35.59
-11.05
Mar2023 40.01
-13.14
Mar2022 46.06 -

Other Financial Ratios of ANTHEM BIOSCIENCES


Compare Core EBITDA Margin ratio of peers of ANTHEM BIOSCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ANTHEM BIOSCIENCES ₹49,697.9 Cr -1.9% 2.3% 10.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,476.0 Cr -0.5% -3% 16% Stock Analytics
DIVIS LABORATORIES ₹254,764.0 Cr 1.6% 9.3% 54.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,423.0 Cr 3.5% 2.3% 40.6% Stock Analytics
CIPLA ₹111,484.0 Cr 1.6% -3.2% -11.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,005.0 Cr 5.8% 3.2% -8.3% Stock Analytics


ANTHEM BIOSCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ANTHEM BIOSCIENCES

-1.9%

2.3%

10.6%

SENSEX

0.7%

-3.9%

-8.9%


You may also like the below Video Courses